Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Primate cell – per se
Reexamination Certificate
2005-10-07
2008-12-09
Campbell, Bruce (Department: 1648)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Primate cell, per se
Reexamination Certificate
active
07462485
ABSTRACT:
The present invention provides modified erythrocytes which comprise viral receptor proteins capable of mediating entry of respective viruses into the modified erythrocytes. The present invention also provides methods of using the modified erythrocytes for the treatment or prevention of viral infections. In one embodiment, the modified erythrocytes of the present invention comprise CD4 and at least one HIV coreceptor, such as CXCR4 or CCR5. The modified erythrocytes, when administered to an HIV patient, bind to the plasma virus and induce the injection of the HIV ribonucleoprotein complex into the cells. The entrapped viral content is either degraded or deactivated within the erythrocytes, or destroyed by erythrophagocytosis.
REFERENCES:
patent: 4356172 (1982-10-01), Nakao et al.
patent: 5061620 (1991-10-01), Tsukamoto et al.
patent: 5236835 (1993-08-01), Mouneimne et al.
patent: 5612207 (1997-03-01), Nicolau et al.
patent: 5763197 (1998-06-01), Tsukamoto et al.
patent: 5798206 (1998-08-01), Neurath et al.
patent: 6130207 (2000-10-01), Dean et al.
patent: 6147052 (2000-11-01), Chau
patent: 6245207 (2001-06-01), Yasuda et al.
patent: 6333171 (2001-12-01), Klatzmann et al.
patent: 6361998 (2002-03-01), Bell et al.
patent: 6482585 (2002-11-01), Dottori
patent: 6514758 (2003-02-01), Wong
patent: 6623937 (2003-09-01), Bonini et al.
patent: 6656471 (2003-12-01), Sastry et al.
patent: 6720325 (2004-04-01), Miller
patent: 6797462 (2004-09-01), Kappes et al.
patent: 2001/0006772 (2001-07-01), Goldstein et al.
patent: 2003/0207247 (2003-11-01), Stassinopoulos et al.
patent: 2004/0146846 (2004-07-01), Dottori
patent: 2004/0243105 (2004-12-01), Swan et al.
Zeira et al., Full-length CD4 electroinserted in the erythrocyte membrane as a long-lived inhibitor of infection by human immunodeficiency virus, Proc. Natl. Acad. Sci., 1991, 88:4409-4413.
Hannig et al., Stability and immunological reactivity of recombinant membrane CD4 electroinserted into the plasma membrane of erythrocytes, FEBS Letters, 1995, 359:9-14.
Cournoyer et al., Gene Therapy of the Immune System, Annual review of immunology, 1993, 11:297-329.
Lachgar et al., Biomed & Pharmacother, Binding of HIV-1 to RBCs involves the Duffy Antigen Receptors for Chemokines (DARC), 1998, 52:436-439.
J. Anderson et al.,Retroviriology 2005,CXCR2 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection, 2:53, pp. 1-11 (2005).
BBC News,‘Test tube’ hope for hep C drug, (2005), pp. 1-3.
N. Cheonis,Bulletin of Experimental Treatments for AIDS,“Structured Treatment Interruption: Future Protocol or Wishful Thinking?”, San Francisco Aids Foundation, Spring 2000, pp. 1-22.
R.J. Cherry et al.,The Journal of Cell Biology,“Detection of Dimers of Dimers of Human Leukocyte Antigen (HLA)-DR on the Surface of Living Cells by Single-Practice Fluorescence Imaging”, vol. 40, No. 1, Jan. 12, 1998 pp. 71-79.
M.P. Fache et al.,The Journal of Cell Biology,“Endocytotic elimination and domain-selective tethering constitute a potential mechanism of protein segregation at the axonal initial segment”, vol. 166, No. 4, Aug. 16, 2004, pp. 571-578.
A.M. Fonseca et al.,Blood,Red blood cells inhibit activation-induced cell death and oxidative stress in human peripheral blood T lumphocytes, vol. 97, No. 10, May, 15, 2001, pp. 3152-3160.
T.B.H. Geijtenbeek et al.,The Journal of Biological Chemistry,“Identification of Different Binding Sites in the Dendritic Cell-specific Receptor DC-Sign for Intercellular Adhesion Molecule 3 and HIV-1”, vol. 277, No. 13, (2002), pp. 11314-11320.
W.C. Greene et al.,HIV InSite,“Molecular Insights Into HIV Biology”, Feb. 2003, pp. 1-20.
P.D. Kwong et al.,Journal of Virology,“Oligomeric Modeling and Electrostatic Analysis of the gp120 Envelope Glycoprotein of Human Immunodeficiency Virus”, vol. 74, No. 4, Feb. 2000, pp. 1961-1972.
Y. Mouneimne et al.,Biochimica et Biophysica Acta,“Electroinsertion of full length recombinant CD4 into red blood cell membrane”, 1027, (1990), pp. 53-58.
Y. Mouneimne et al.,Biochimica et Biophysica Acta,“Electroinsertion of xeno proteins in red blood cell membranes yields a long lived protein carrier in circulation”, 1066, (1991), pp. 83-89.
NIAID Division of Aids,“HIV Summary of Research Advances”, (2002), pp. 1-4.
Project Reform,Understanding HIV: Co-Receoptors—CCR5,“discovery of immune cell proteins shows promise for new therapies”, (2004), pp. 1-4.
U. O'Doherty et al.,Journal of Virology,“Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding”, vol. 74, No. 21, Nov. 2000, pp. 10074-10080.
E.J. Platt et al.,Journal of Virology,“Kinetic Factors Control Efficiencies of Cell Entry, Efficacies of Entry Inhibitors, and Mechanisms of Adaptation of Human Immunodeficiency Virus”, vol. 79, No. 7, Apr. 2005, pp. 4347-4356.
S. Raffy et al.,Biophysical Journal,“Control of Lipid Membrane Stability by Cholesterol Content”, vol. 76, Apr. 1999, pp. 2072-2080.
S. Raffy et al.,The Journal of Biological Chemistry,“Electroinsertion of Glycophorin A in Interdigitation-Fusion Giant Unilamellar Lipid Vesicles”, vol. 272, No. 41, (1997), pp. 25524-25530.
A. Stromberg et al.,PNAS,“Manipulating the genetic identity and biochemical surface properties of individual cells with electric-field-induced fusion”, vol. 97, No. 1, Jan. 4, 2000, pp. 7-11.
D. Tagliasacchi et al.,Fun Science Gallery,“Let's Observe the Blood Cells”, Apr. 1997, pp. 1-17.
Helmut Dolznig et al., “Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays1”, The FASEB Journal, vol. 15, Jun. 2001, pp. 1442-1444.
Alena Leroux et al., “Transcriptional and translational mechanisms of cytochrome β5reductase isoenzyme generation in humans”, Biochem. J. (2001) vol. 355, pp. 529-535.
Punam Malik et al., “An In Vitro Model of Human Red Blood Cell Production From Hematopoietic Progenitor Cells”,,Blood,vol. 91, No. 8, Apr. 15, 1998, pp. 2664-2671.
Britta Hardy et al., “Spectrin Rearrangement Early In Erythrocyte Ghost Endocytosis”, J. Cell Biology, The Rockefeller Univerity Press, vol. 82, Sep. 1979, pp. 654-663.
Kiaran Kirk, “Membrane Transport in the Malaria-Infected Erythrocyte”, Physiological Reviews, vol. 81, No. 2, Apr. 2001, pp. 495-537.
Campbell Bruce
Kinsey White Nicole
LandOfFree
Modified erythrocytes and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified erythrocytes and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified erythrocytes and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4022275